National Aeronautics and Space Administration October 2, 2015 – Federal Register Recent Federal Regulation Documents

This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially-exclusive license in the United States to practice the invention described and claimed in U.S. Patent No. 7,623,972 for an invention entitled ``Detection of Presence of Chemical Precursors''; U.S. Patent No. 7,801,687 for an invention entitled ``Chemical Sensors Using Coated or Doped Carbon Nanotube Networks''; U.S. Patent No. 7,968,054 for an invention entitled ``Nanostructure Sensing and Transmission Of Gas Data''; and U.S. Patent No. 8,000,903 for an invention entitled ``Coated or Doped Carbon Nanotube Network Sensors as Affected by Environmental Parameters''; and ARC-16902-1 for an invention entitled ``Nanosensors for medical diagnosis''; and ARC- 16292-1 for an invention entitled ``Nanosensor/Cell Phone Hybrid for Detecting Chemicals and Concentrations,'' to The Medical Innovation Group, LLC, having its principal place of business at 416 Mount Airy Road, Basking Ridge, NJ 07920. The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially-exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.